Dr. Carolina De jesus-acosta MD

Recommended Articles

• What Is Duchenne Muscular Dystrophy? Causes, Symptoms, and Treatment

  Muscular dystrophies are a group of diseases that make the muscles of the body weaker over a period of time. The muscles become less flexible in this condition. Out of the nine types of muscular dystrophy, Duchenne muscular dystrophy is one of the most common.The main characteristics of this medical...

• Laser Shoes Help Parkinson’s Patients in Freezing Episodes

  As someone gets older, they are more at risk for neurodegenerative diseases. Among these diseases is Parkinson's, which affects a patient's movements and motor skills.Parkinson’s disease does not only result from old age. It also has been shown to occur more frequently among men who are...

• Big Surprise for Young Man with Muscular Dystrophy on his Birthday

  There are many people out there living with great difficulties that they will have to overcome or cope with for the rest of their lives. People suffer muscular problems, mental problems, health problems, and some of them are living with more than one devastating condition.Sometimes, these problems...

• Immunosuppressive Drugs for Multiple Sclerosis

  What is multiple sclerosis (MS)?Multiple sclerosis is a medical condition that affects the brain and the spinal cord. A few of the early symptoms of the disease are numbness, tingling sensation, blurry vision, and feeling weak. In this disease, the immune system tends to attack the myelin, which is...

• What Funding and Research Is There for Parkinson's Disease?

  Researchers and fundraisers are upbeat and optimistic that one day they will find a cure for the condition. Research is also driven by people affected by Parkinson’s disease (PD). The aim of researchers is to control the progression of the disease, prevent the disease altogether and restore lost...

• Nortis Inc. Receives $688K to Revolutionize Multiple Sclerosis Treatment

  One Seattle-based technology recently revealed new clinical technology that could completely change the way multiple sclerosis is treated. The firm received $668,000 to develop an in-vitro blood barrier that mimics the human blood-brain barrier, an innovation that would make MS drug development more...